Taken together, these results indicate that NTs exert a critical role on fibroblast and could be involved in tissue remodelling and wound healing.
Introduction
Neurotrophin (NT) family comprises a group of functionally and structurally related proteins that play a fundamental role in the survival and differentiation of neuronal cells (Ernsberger et al, 2009) . NT family includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4). These proteins exert their effects through the binding and activation of two kinds of transmembrane receptors, the low-affinity receptor p75NTR, which interacts with all of the NT with the same affinity, and the high-affinity receptors Trk (TrkA, TrkB and TrkC), which bind a particular NT (Snider, 1994) . NTs are synthesized and released by many skin cells that also express NT receptors, thus creating a complex network between the different cellular populations (Botchkarev et al, 2006) . Therefore, in skin, NTs act not only as trophic molecules for skin innervation but also as growth/survival factors for skin cells, being involved in different autocrine and paracrine functions (Peters et al, 2007) .
Fibroblasts (DF) represent the main cellular component of the dermis, and are implicated in the homeostatic maintenance of skin extracellular matrix (ECM). They are metabolically active cells and their role is associated with the synthesis and secretion of collagens, proteoglycans, fibronectin and metalloproteases. Dermal fibroblasts play a role in different physiopathological processes in the skin, including wound healing and fibrosis (Werner et al, 2007; Krieg et al, 2007) . After injury, different factors, in particular TGF-β 1 (Desmoulière et al, 2003) , promote DF differentiation into myofibloblasts (DM), characterized by the expression of α-Smooth Muscle Actin (α-SMA) (Hinz, 2007) , which is therefore used as DM differentiation marker. DM are the key effectors in injury/repair processes and fibrosis, as they control ECM component deposition, tissue contraction and wound resolution (Hinz, 2007) , and their subsequent apoptosis is essential for the tissue re-epithelization (Desmoulière et al, 2005) .
While the expression and function of NTs and their receptors in keratinocytes and melanocytes were extensively studied (Marconi et al, 2003; Marconi et al, 2006) , little is known on the correlation between NTs and fibroblasts. In the corneal and muscular systems, NGF promote fibroblast migration and differentiation into DM (Hasan et al, 2000; Micera et al, 2007; Poduslo et al, 1998) .
In the present work, we report that DF and DM express all NTs and their receptors. We also show that NTs promote fibroblast survival, differentiation and migration. Finally, NTs can stimulate fibroblast contraction in a 3D collagen system.
Material and methods

Cell cultures
Human dermal fibroblasts were obtained by explant culture from foreskin and grown in Dulbecco's modified Eagle's medium (DMEM) containing 5% fetal bovine serum S. TGF-β 1 (1 ng/ml, Sigma, St. Louis, MO) was added in fibroblast secondary culture for six days to promote differentiation into myofibroblasts. The myofibroblast phenotype was check by immunostaining of α-SMA.
Immunofluorescence
Human dermal fibroblasts were plated into chamber slides and stimulated or not with 100ng/ml TGF-β 1 or 100ng/ml recombinant NT (NGF, BDNF, NT-3 or NT-4) (Sigma) in medium with BSA 0,1%. After six days, cell were washed in PBS and fixed in situ in 3,6% formaldehyde for 20 minutes. After washing, cells were permeabilized by incubation for 5 minutes with 0.5% Triton X-100, for 15 minutes with 0.5% bovine serum albumin and 5% goat serum, and then for 60 minutes at 37°C with the mouse monoclonal α-SMA antibody (1:400, Sigma, St Louis, MO). After a brief washing, the cells were incubated for 60 minutes with the secondary antibody anti-mouse AlexaFluor 488 (1:130 dilution) (Molecular Probe Inc, Eugene, OR, USA). Fluorescent specimens were analyzed by a confocal scanning laser microscope (Leica TCS SP2; Leica, Heerbrugg, Switzerland).
NT ELISA assay
Dermal fibroblasts and myofibroblasts were plated and cultivated in 60 mm 2 tissue culture petri dishes. The medium was changed with 2 ml of medium with BSA 0,1% 24 hrs after seeding. Cells were lysed in 100 µl of RIPA buffer pH 7.4 (50mM Tris-HCl, 150mM NaCl, 1% deoxycolate, 1% TritonX-100, 0.1% SDS, 0.2% sodium azide) and conditioned medium were collected and storaged with protease inhibitor. Media were store for 48 hrs at -80°C. The NGF, BDNF, NT-3 and NT-4 quantitation was performed by a two-site enzyme 
Western blotting analysis
Cells were washed with PBS and lysed on ice, for p75NTR, α-SMA, cyclin B and procaspase-3 detection in lysis buffer pH 7.5 (NaCl 150mM, MgCl 15mM, EGTA 1mM, HEPES 50mM, Glicerolo 10%, Triton 1%), for Trks detection in lysis buffer pH 7.4 (50mM Tris-Hcl, 1% NP40, 0.25% sodium deoxycholate, 150mM
NaCl, 1mM EGTA, 1mM Na 3 VO 4 , 1mM NaF) containing protease inhibitors, as described previously (Marconi et al, 2003 
Reverse transcription and polymerase chain reaction (RT-PCR)
Total cellular RNA was extracted from cultures using TRI Reagent method performed as described by Sigma. One microgram of total cellular RNA extracted was reverse-transcribed and amplified as described (Pincelli et al, 1994) . To verify the integrity of the RNA in each sample, the α- Results are calculated as the mean ± SD of three different experiments.
Migration assay
A total of 200,000 dermal fibroblasts were plated on 12-well tissue culture plates and then treated with 5 µg/ml mitomycin C for 1 hour and 30 minutes.
Subsequently, the cells were washed three times in serum-free medium and a line for each well were drawn along the cell monolayer with a sterile plastic tip.
Plates were washed twice with serum-free medium to remove all detached cells and incubated in medium with BSA 0,1% with 100ng/ml TGF-β 1 , 100ng/ml human recombinant NT (Sigma-Aldrich, St Louis, MO), 2 µg/ml 
Tensile strength measurement
Contractile strengths were measured with the GlaSbox ® device as already described by Viennet (Viennet et al, 2005) . This box contains 8 rectangle plates in which living dermal equivalents (LDE) are placed and maintained by 2 thin flexible silicium blades with a grid in its inferior part on which LDE attach after a few minutes polymerisation. LDE are composed of 6 volumes of 1.76 concentrated DMEM, 3 volumes of 2mg/ml type I collagen and 1 volume of a 8.10 5 fibroblasts/ml suspension. During contraction of the LDE, the gold covering blades get out of shape inducing changes in the electrical resistance measured by a Wheastone bridge. Variations are registered real time for 24
hours by a computer and converted as milliNewton (mN). The effects of neurotrophin concentrations (10-100ng/ml; Sigma-Aldrich, St Louis, MO) were examined in triplicate and positive (2.5ng/ml TGF-b 1 , Sigma-Aldrich, St Louis, MO) and neutral control (DMEM alone) were performed.
Statistical Analysis
Results from each experiments were analysed by Student's T-Test, obtaining a p-values refered to the mean comparison between treated samples and its controls in each triplicate experiment.
Results
DF and DM synthesize and secrete all NTs and express NT receptors
It was previously demonstrated that epidermal cells express NT and their receptors at different levels and that NTs are implicated in different physiopathological processes in the skin (Botchkarev et al, 2006) . In order to evaluate the role of these proteins also in DF and DM, we have analyzed their production in fibroblasts with or without treatment with TGF-β1 (Figure 1a-b) .
We have observed that DF and DM synthesize and release NTs, although at different levels, as shown by ELISA Assay (Figure 1c-1f) . Overall, the more differentiated DM release higher levels of NTs than DF. In particular, DF and DM synthetize highest levels of NT-3 and NT-4, while they release NGF, NT-3 and NT-4 in similar amounts. BDNF is expressed at low levels in both cell lysates and in the medium.
In order to evaluate whether DF and DM could also be the target of NTs, we have analyzed NT receptor expression at the mRNA and protein levels. Both DF and DM express TrkA, TrkB, TrkC and p75NTR mRNA, as shown by RT-PCR (Figure 1g ). NT receptor expression is also confirmed by Western Blotting (Figure 1h ). DF express TrkA protein at higher levels than DM, while TrkB and p75NTR are expressed at higher levels in DM than in DF. TrkC protein is slightly more expressed in DM than in DF. These findings suggest that DF and DM could participate in the NT network not only by releasing NTs but also by responding to their action.
NTs maintain DF and DM viability through Trk receptors.
Given that DF and DM express NT receptors and release NTs, we first analyzed the effect of endogenous and exogenous NT on DF and DM proliferation. When NT were added (100ng/ml) to fibroblast and myofibroblast cultures, no effect was observed on their proliferation up to 72 hrs (Figure 2a- 
NTs maintain DF viability through p75NTR.
Because p75NTR can act as a co-receptor that refines Trk affinity and specificity for NT, we investigated its role in DF proliferation. To this purpose, we silenced p75NTR by siRNA (100nM) (Figure 3a ) and evaluated DF proliferation. p75NTR siRNA-treated DF proliferated to a significantly lesser extent, as compared to DF treated with scrambled siRNA (Figure 3b ). p75NTR siRNA-treated DF underwent G2-M arrest, as shown by increased cyclin B expression at 48 hrs, while caspase-3 was not activated (Figure 3c ).
These findings indicate that p75NTR co-operates with Trk receptors to mediate DF proliferation induced by autocrine NTs.
Neurotrophins promote DF differentiation into DM
It has been shown previously that NTs mediate differentiation in neuronal and non-neuronal cells (Spittau et al, 2010) , and NGF can induce a-SMA expression in lung and skin fibroblasts, with an effect comparable to that of TGF-β 1 (Micera et al, 2006) . 24 hrs after treatment with NGF, BDNF, NT-3 or NT-4, α-SMA expression was induced to the same extent as after stimulation with TGF-β 1 (Figure 4a ). α-SMA protein expression was maintained for six days after addition of all NTs with a pattern similar to that induced by TGF-β, (Figure 4a-b ). This finding indicates that NTs induce the differentiation of DF into DM at early and later points, with the same TGFβ 1 kinetics.
Neurotrophins induce DF migration
Fibroblast migration plays an essential role in several physiopathologic processes at the skin level, including wound healing (Walter et al, 2010) and melanoma progression (Wu et al, 2010) . Because NTs are involved both in wound healing (Sun et al, 2010 ) and in melanoma cell migration (Truzzi et al, 2008) , we wanted to investigate the migratory capacity of fibroblasts after treatment with NTs ( Figure 5a ). NGF, BDNF, NT-4 or NT-3 stimulated DF migration in a statistically significant fashion both at 24 and 48 hrs, as This indicates that autocrine and paracrine NTs promote DF migration through the combined activity of NT receptors.
NGF and BDNF stimulate dermal fibroblast contraction in vitro
In order to evaluate DF contraction we have used GlaSbox®, a previously described device that measures tensile strength generated by human dermal fibroblasts embedded in a collagen gel to create a Living Dermal Equivalent (LDE) (Viennet et al, 2005) . All generated curves exhibit 2 distinct phases: the first 8 hrs phase shows a fast increase of the contractile strength reaching a maximum and then a 8h to 24h phase with a maximal and constant contractile strength.
We analyzed the effect of NTs on the contractile strength in the GlaSbox. NGF significantly stimulated contractile strength in a dose dependent manner, as compared to controls, while only 100ng/ml dose was as effective as TGF-β 1 , used as a positive control (Figure 7a ). The maximal strength was reached around 8-10 hrs with 100ng/ml and 50ng/ml. BDNF significantly stimulated the contractile strengths at 8 hrs only with 100ng/ml dose, although it was less effective than NGF at the same dose (Figure 7b ). Contractile properties of NGF and BDNF were observed in the collagen gel, after extraction of the LDE from the GlaSbox® (Figure 7c and d) . By contrast NT-3 and NT-4 failed to exert any effect on the contractile strength (Figure 7e , f, g and h).
Discussion
NTs form an intricate system at the epidermal level where they are released by several cell types which in turn express NT receptors (Raap and Kapp, 2010; Botchkarev et al, 2006) . Fibroblasts participate in a number of critical functions in the skin, such as tissue remodeling and fibrosis (Werner et al, 2007; Krieg et al, 2007) . Furthermore, fibroblasts play an important role in the skin immune system, as they promote the migration of dendritic cells and support the expansion of IL-17 producing T cells Albanesi et al, 2009; Schirmer et al, 2010) . Fibroblasts together with the ECM are also essential for tumor invasion and metastasis (Li et al, 2009) . In this work, we demonstrate that NTs, by modulating several fibroblast functions, extend their influence also in the dermis, making the skin NT network more and more complex.
We have shown that DF and DM synthesize and release all NTs and express both the high affinity receptors, TrkA, TrkB and TrkC, and the low affinity receptor p75NTR. In particular, NGF and NT-3 are secreted at higher levels than other NTs, and DM produce higher amounts of NT than DF.
It has already been shown that NGF is released by damage tissues (Hattori et al, 1996) . In this context, metabolically active DM could release NGF and NT-3 and stimulate tissue remodeling. Interestingly, NGF and NT-3 also induce keratinocyte proliferation (Marconi et al, 2003) , suggesting that these NTs act on the two most important cells involved in wound healing. While TrkA is more expressed in DF than in DM, p75NTR is almost exclusively expressed in DM, in agreement with data reported for the corneal system (Micera et al, 2006) . It is conceivable that NGF and NT-3 stimulate the differentiation of DF into DM through TrkA and initiate tissue remodeling. On the contrary, in DM, p75NTR
could act as death receptor, as demonstrated in other systems, where p75NTR activation contributes to DM elimination in the final phase of the wound healing process (Desmoulière et al, 1995) . Consistently, p75NTR-mediated apoptosis of DM is also necessary to prevent hepatic fibrosis (Kendall et al, 2009 ).
Exogenous NTs per se fail to stimulate DF and DM proliferation, possibly because endogenous production of NTs is sufficient to normal cell proliferation and survival. However, blocking their signaling pathway, through inhibition of Trk receptors, in absence of exogenous NTs, strikingly reduces DF and DM proliferation, in agreement with previous reports where the use of chimeric receptor that block Trk activity, inhibit cell proliferation in melanoma cell lines (Truzzi et al, 2008) . In particular, inhibiting Trk receptor signalling induces DF and DM G0-G1 arrest, and caspase-3 activation, further confirming the importance of NT in maintaining DF and DM viability through Trk receptors. On the other hand, blocking p75NTR promotes G2-M arrest, demonstrating that in this context p75NTR only acts as Trk co-receptor.
Interestingly, NTs also promote DF differentiation into DM, by inducing α-SMA expression, indicating that NTs could have a functional role in the fibromyofibroblasts system. In fact, it has been shown that NGF induce fibroblastlike keratinocyte differentiation into DM (Micera et al, 2001; Micera et al, 2007a) , their contraction in 3D collagen matrix (Micera et al, 2001 ) and the expression of MMP-9 (Metalloprotease-9) in keratoconjunctivitis-derived fibroblasts (Micera et al, 2007b) and different works show the applicative possibility of this NGF capacity (Landi et al, 2003; Aloe et al, 2008; Sun et al, 2010) .
DF migration and contractile strength are critical for matrix remodeling (Rhee, 2009 ). We have demonstrated that all NTs promote DF migration while NGF, and BDNF promote DF contractile activity. Therefore NGF and BDNF, produced GlaSbox devices and stimulated with TGF-β 1 (100ng/ml) or NGF, BDNF, NT-3 or NT-4 at the concentration of 1ng/ml, 10ng/ml or 100ng/ml for each stimulus or neutral control (DMEM alone). Tensile strenght generated from each LDE was measured as changes in elettrical resistence by a Wheaston bridge and converted in milliNewton (mN) by a computerized system. Data are expressed as the mean of three different experiments. Each GlaSbox device, containing LDE, was observed and photographed after 24 hours.
